Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX) Stock Information | RedChip

Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX)


$7.9900
+0.1400 ( -0.25% ) 367.0K

Amneal Pharmaceuticals Inc is a global pharmaceutical company operating primarily in the U.S., India, and Ireland. With three reportable segments; Generics, Specialty, and AvKARE - It develop, manufacture, and distribute a diverse portfolio of essential medicines. The Generics segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.

Market Data


Open


$7.9900

Previous close


$7.8500

Volume


367.0K

Market cap


$2.47B

Day range


$7.5800 - $8.1000

52 week range


$5.0100 - $9.4750

SEC Filings


Form Type Description Pages Date
10-q Quarterly Reports 102 Aug 09, 2024
8-k 8K-related 16 Aug 09, 2024
4 Insider transactions 1 May 20, 2024
4 Insider transactions 1 May 14, 2024
4 Insider transactions 1 May 14, 2024
4 Insider transactions 1 May 14, 2024

Latest News